Emilio Burgos
La Paz, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Transcriptional Regulator CNOT3 Defines an Aggressive Colorectal Cancer Subtype.
Journal: Cancer research
Published: May 13, 2016
Chromatin immunoprecipitation from fixed clinical tissues reveals tumor-specific enhancer profiles.
Journal: Nature medicine
Published: January 20, 2016
Pharmacogenetic predictors of outcome in patients with stage II and III colon cancer treated with oxaliplatin and fluoropyrimidine-based adjuvant chemotherapy.
Journal: Molecular cancer therapeutics
Published: July 02, 2014
Clinical relevance of the differential expression of the glycosyltransferase gene GCNT3 in colon cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 07, 2014
Genes associated with metabolic syndrome predict disease-free survival in stage II colorectal cancer patients. A novel link between metabolic dysregulation and colorectal cancer.
Journal: Molecular oncology
Published: January 16, 2014
Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 20, 2013
Cephalic pancreaticoduodenectomy for bleeding duodenal arteriovenous malformation.
Journal: European journal of pediatric surgery reports
Published: July 17, 2013
Upregulation of trefoil factor 3 (TFF3) after rectal cancer chemoradiotherapy is an adverse prognostic factor and a potential therapeutic target.
Journal: International journal of radiation oncology, biology, physics
Published: December 23, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026